Bojesen, Stig E, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, et al. 2013. “Multiple Independent Variants at the TERT Locus Are Associated with Telomere Length and Risks of Breast and Ovarian Cancer.” Nat Genet 45 (4) (March 27): 371–384. doi:10.1038/ng.2566.
Chornokur, G., H. Lin, J. P. Tyrer, K. Lawrenson, J. Dennis, E. K. Amankwah, X. Qu, et al. 2015. “Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.” PLoS ONE 10 (6): e0128106. doi:10.1371/journal.pone.0128106. http://dx.doi.org/10.1371/journal.pone.0128106.
Goode, Ellen L, Georgia Chenevix-Trench, Honglin Song, Susan J Ramus, Maria Notaridou, Kate Lawrenson, Martin Widschwendter, et al. 2010. “A Genome-Wide Association Study Identifies Susceptibility Loci for Ovarian Cancer at 2q31 and 8q24.” Nat Genet 42 (10) (September 19): 874–879. doi:10.1038/ng.668.
Kuchenbaecker, K. B., S. J. Ramus, J. Tyrer, A. Lee, H. C. Shen, J. Beesley, K. Lawrenson, et al. 2014. “Identification of six new susceptibility loci for invasive epithelial ovarian cancer.” Nature genetics 47 (2): 164-171. doi:10.1038/ng.3185. http://dx.doi.org/10.1038/ng.3185.
Southey, M. C., D. E. Goldgar, R. Winqvist, K. Pylkäs, F. Couch, M. Tischkowitz, W. D. Foulkes, et al. 2016. “PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.” Journal of medical genetics 53 (12): 800-811. doi:10.1136/jmedgenet-2016-103839. http://dx.doi.org/10.1136/jmedgenet-2016-103839.
Quick submit: 2017-05-13T17:07:28-0400 Hollestelle, Antoinette, Frederieke H. van der Baan, Andrew Berchuck, Sharon E. Johnatty, Katja K. Aben, Bjarni A. Agnarsson, Kristiina Aittomäki, et al. 2016. “No Clinical Utility of KRAS Variant Rs61764370 for Ovarian or Breast Cancer.” Gynecologic Oncology 141 (2) (May): 386–401. doi:10.1016/j.ygyno.2015.04.034.